CANOVA (Multiple Myeloma - Recruitment: CLOSED)

Project Title

A Study of Venetoclax and Dexamethasone Compared With Pomalidomide and Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma (CANOVA).

Official Title

A Phase III, Multicenter, Randomized, Open Label Study of Venetoclax and Dexamethasone Compared With Pomalidomide and Dexamethasone in Subjects With t(11;14)-Positive Relapsed or Refractory Multiple Myeloma.

Project Summary

A study designed to evaluate the safety and efficacy of venetoclax plus dexamethasone (VenDex) compared with pomalidomide plus dexamethasone (PomDex) in participants with t(11;14)-positive Relapsed or Refractory Multiple Myeloma.

Blood Disorder

t(11;14)-positive Relapsed Multiple Myeloma
Refractory Multiple Myeloma

Patient Recruitment Details

Patient recruitment status: closed

Number of Patients (Globally)

244 participants.

Latest

Gemma's story

No one wants to face it; I didn't look like a cancer patient.
Myelofibrosis (MF)

Myelofibrosis is an uncommon type of blood cancer that interrupts the body’s normal production of blood cells.
Andrew's story

Andrew was diagnosed with myelofibrosis in 2021, an uncommon form of blood cancer affecting the bone marrow. Learn more about Andrew's story here.
Rare Disease Day 2023

February 28 is Rare Disease Day. This global initiative provides an opportunity to increase awareness about rare disorders which can affect everyone.

COVAXI-2 (Haematological diseases - RECRUITMENT: OPEN)

This is an observational Cohort study to assess the immune response to the SARS-CoV-2 vaccination and the prevalence of clotting related antibodies in haematology and other immunosuppressed patients.
EXCALIBER-RRMM (Multiple Myeloma - RECRUITMENT: OPEN)

A Phase 3 study comparing the efficacy and safety of IberDd versus DVd in participants with relapsed or refractory multiple myeloma (RRMM).
ADVANCE SC+ (Thrombocytopenia - RECRUITMENT: OPEN)

A Phase 3 study to evaluate the safety and efficacy of efgartigimod PH20 subcutaneous in adult patients with primary immune thrombocytopenia
COASTAL (Indolent Non-Hodgkin's Lymphoma - RECRUITMENT: OPEN)

This is an open label, randomized, two-arm Phase 3 study in subjects with relapsed or refractory FL and MZL to evaluate efficacy and safety of zandelisib in combination with rituximab in comparison to standard immunochemotherapy (Rituximab-Bendamustine or Rituximab-CHOP).
InMIND (Follicular Lymphoma or Marginal Zone Lymphoma - RECRUITMENT: OPEN)

This is a Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Tafasitamab Plus Lenalidomide in Addition to Rituximab Versus Lenalidomide in Addition to Rituximab in Patients With Relapsed/Refractory (R/R) Follicular Lymphoma Grade 1 to 3a or R/R Marginal Zone Lymphoma
Dose-Escalation and Expansion Study of BGB-16673 (B-Cell Malignancies - RECRUITMENT: OPEN)

This study consists of two parts to explore BGB-16673 recommended dosing.
An Extension Study of Venetoclax (RECRTUITMENT: OPEN)

This is an extension study to provide venetoclax and obtain long-term safety data for subjects who continue to tolerate and derive benefit from receiving venetoclax in ongoing studies.
Phase 1b study of BMS-986158 Monotherapy (Myelofibrosis - RECRUITMENT: OPEN)

The purpose of this study is to assess the safety, tolerability, and efficacy of BMS-986158 alone and in combination with either Ruxolitinib or Fedratinib.
ADVANCE SC (Idiopathic Thrombocytopenia Purpura - (RECRUITMENT: OPEN)

This is a phase 3, multicenter, randomized, double-blinded, placebo-controlled, parallel-group trial to evaluate the efficacy, safety, and effect on QoL/PRO of efgartigimod PH20 SC treatment in adult patients with primary ITP.
PACIFICA (Myelofibrosis Phase 3 study - RECRUITMENT: OPEN)

A Phase 3 Study of Pacritinib in Patients With Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis

What is thrombosis?

Click here to learn more about thrombosis.
What are DVT & PE?

Click here to learn more about DVT and PE.
Antiphospholipid Antibody Syndrome

Click here for information about antiphospholipid antibody syndrome and how it can lead to thrombosis.
Work and Thrombosis

Click here to learn more about how work can increase your risk of thrombosis, and how to prevent it.
Contraception and Thrombosis

Click here to learn more about how certain contraceptives can increase your risk of dangerous blood clots.
Inherited Thrombophilias

Click here for information about genetic conditions that can increase the chances of thrombosis.
Investigators
Travel and Thrombosis

Click here to learn about how travel can increase your risk of developing dangerous blood clots.
Participate in a clinical trial

PBI's Clinical Trials Unit actively runs numerous clinical trials and performs state-of-the-art research into bleeding and clotting disorders and blood cancers.
Pregnancy and Thrombosis

Click here to learn about how pregnancy can increase your risk of thrombosis.

Donate today

Please help to make blood disorders a thing of the past. Every amount is vital to our research, no matter how large or small. Read more

Donate

Elie's story

When Elie was a young, fit and healthy 22-year-old he noticed a lump in the side of his neck. He went to his GP complaining of fatigue, insomnia, and severe itching. After being misdiagnosed with glandular fever and then a mystery virus, he received a call from his doctor. Read more